Targeting RNA binding proteins with small-molecule inhibitors: Advances, challenges, and therapeutic opportunities

RNA-binding proteins (RBPs) constitute central regulators of post-transcriptional gene expression and have been increasingly recognized as critical contributors to the pathogenesis of cancer, neurodegenerative disorders, and autoimmune diseases. However, in contrast to well-established drug targets...

Descripción completa

Detalles Bibliográficos

Autores principales:	Yuning Shi, Dazhi Feng, Jieya Zhou, Lihua Liu, Xinnan Li, Zhenwei Yuan, Jianbing Wu, Hong Yao
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Elsevier 2026-03-01
Colección:	Acta Pharmaceutica Sinica B
Materias:	RNA binding proteins Post-transcriptional gene expression Disease Small-molecule modulators High-throughput screening Chemical biology approaches
Acceso en línea:	http://www.sciencedirect.com/science/article/pii/S2211383525008172
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!